Join the conversation on LinkedIn MADISON, Wis., October 14, 2026 – Cellular Logistics Inc., a Madison-based regenerative medicine company, today announced an award through the Innovation to Commercialization Pipeline (ICP) program, offered by Forward BIOLABS in partnership with BioForward Wisconsin. The award will fund a seven-month commercialization-readiness project for...
MADISON, Wis., January 20, 2026 – Cellular Logistics Inc., a pioneering Madison-based biotechnology company dedicated to transforming the treatment of heart disease through innovative regenerative medicine, today announced the receipt of new funding specifically earmarked for the development of potency assays critical to its flagship...
Interested in learning more about the Catalyze program? Join us on March 19 at 12pm ET for a live webinar where a panel of four funded investigators will describe their Catalyze project and summarize key takeaways from the program. Time will be reserved for audience questions. March...
https://wisconsinctc.org/client-successes/cell-logistics/...
https://innovate.wisc.edu/partnership-accelerates-transition-of-uw-madison-technologies-from-lab-to-market/ ...
Madison, WI, January 9, 2024 – Cellular Logistics Inc. (CL) in Madison, Wisconsin, and Allele Biotechnology Inc. (ALLELE) in San Diego, California, have entered a collaboration to develop regenerative medicine products to treat ischemic heart disease. The relationship has been recently bolstered by the Catalyze award that...
Cellular Logistics Receives Second SBIR Advance Award...
MADISON, Wis., October 24, 2022 – Cellular Logistics has been awarded a $337,000 SBIR grant from the National Institutes of Health to further evaluate the functional immune and angiogenic (blood vessel growth) responses of the company's Cardiac Fibroblast Matrix product, CFX™ Solus, for the treatment...
New study identifies protein essential to form stem cell-derived human heart cells...
MADISON, WI, May 16, 2022 – Cellular Logistics, a Madison, Wisconsin company that is creating a new way to restore heart function and help patients with heart damage is launching a new financing round to advance its product, Tandem™, to the next stage of product development, and moving...